Researchers investigated the increased incidence of group A streptococci (GAS) infections.
Sofinnova’s Maha Katabi on recent M&A and IPO success and how deal flow has ‘never been any better’
Maha Katabi has had a great three months. The Sofinnova general partner has been in the boardroom of two recent M&A exits: radiopharmaceuticals maker RayzeBio,